Suppr超能文献

导管移除后持续无菌性腹膜炎症预示着难治性细菌性腹膜炎会发展为完全型包裹性腹膜硬化症。

Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis.

机构信息

Renal Unit,1 Department of Medicine and Geriatrics, and Department of Radiology,2 Kwong Wah Hospital, Hong Kong SAR, PR China.

出版信息

Perit Dial Int. 2013 Sep-Oct;33(5):507-14. doi: 10.3747/pdi.2012.00281. Epub 2013 Aug 1.

Abstract

BACKGROUND

Encapsulating peritoneal sclerosis (EPS) is the most serious complication of peritoneal dialysis, having high morbidity and mortality. To improve outcomes, early diagnosis is needed to direct treatment during the early inflammatory phase. However, in the early inflammatory phase, clinical features are nonspecific, and no reliable diagnostic criteria have been established. Because bacterial peritonitis and termination of dialysis are two important risk factors triggering the progression of EPS, patients with refractory bacterial peritonitis necessitating dialysis catheter removal are at particularly high risk of developing EPS. Many of these patients might indeed experience non-resolving sterile peritonitis (probably the inflammatory phase of EPS) before progression to full-blown disease (that is, the presence of intestinal obstruction). We undertook a retrospective study to compare, in this particular situation, the clinical characteristics of patients with or without sterile peritoneal inflammation, assessing their clinical outcomes in terms of short-term mortality and the chance of developing full-blown EPS.

METHODS

Our retrospective review included 62 patients whose dialysis catheter was removed because of refractory peritonitis between January 2005 and December 2010.

RESULTS

Of the 62 patients identified, 39 (63%) had persistent sterile peritoneal inflammation ("high-risk" group, n = 39), and 23 (37%) had resolution of inflammation without significant intra-abdominal collection after catheter withdrawal ("control" group, n = 23). Compared with the control group, the high-risk group had a significantly longer PD duration (71.6 ± 43.3 months vs 42.3 ± 29.9 months, p = 0.003), a higher dialysate-to-plasma ratio (D/P) of creatinine (0.768 ± 0.141 vs 0.616 ± 0.091, p = 0.004), and a higher computed tomography score for EPS (7.69 ± 2.98 vs 1.00 ± 1.00, p < 0.001). During the 6-month study period, the high-risk group had a higher chance of developing full-blown EPS (31% vs 0%, p = 0.002) and a higher 6-month all-cause mortality (36% vs 4.3%, p = 0.004).

CONCLUSIONS

Persistent sterile peritoneal inflammation was common after dialysis catheter removal for refractory bacterial peritonitis, and the patients with such inflammation were at high risk of progression to full-blown EPS.

摘要

背景

包裹性腹膜硬化症(EPS)是腹膜透析最严重的并发症,发病率和死亡率都很高。为了改善预后,需要早期诊断,以便在炎症早期进行治疗。然而,在炎症早期,临床特征不具有特异性,也没有建立可靠的诊断标准。由于细菌性腹膜炎和透析终止是触发 EPS 进展的两个重要危险因素,因此需要移除透析导管的难治性细菌性腹膜炎患者发生 EPS 的风险特别高。这些患者中的许多人在进展为完全疾病(即存在肠梗阻)之前,实际上可能会经历非缓解性无菌性腹膜炎(可能是 EPS 的炎症期)。我们进行了一项回顾性研究,比较了在这种特殊情况下,有无无菌性腹膜炎症患者的临床特征,并根据短期死亡率和发展为完全 EPS 的机会评估了他们的临床结局。

方法

我们的回顾性研究纳入了 2005 年 1 月至 2010 年 12 月期间因难治性腹膜炎而移除透析导管的 62 例患者。

结果

在确定的 62 例患者中,39 例(63%)持续存在无菌性腹膜炎症(“高危”组,n = 39),23 例(37%)在移除导管后炎症得到缓解,且无明显腹腔积气(“对照”组,n = 23)。与对照组相比,高危组的 PD 持续时间明显更长(71.6 ± 43.3 个月比 42.3 ± 29.9 个月,p = 0.003),肌酐的透析液与血浆比值(D/P)更高(0.768 ± 0.141 比 0.616 ± 0.091,p = 0.004),以及 EPS 的 CT 评分更高(7.69 ± 2.98 比 1.00 ± 1.00,p < 0.001)。在 6 个月的研究期间,高危组发生完全 EPS 的几率更高(31%比 0%,p = 0.002),6 个月全因死亡率也更高(36%比 4.3%,p = 0.004)。

结论

难治性细菌性腹膜炎患者移除透析导管后常出现持续性无菌性腹膜炎症,此类炎症患者进展为完全 EPS 的风险较高。

相似文献

7
[Encapsulating peritoneal sclerosis].[包裹性腹膜硬化症]
Rev Med Chil. 2017 Jan;145(1):41-48. doi: 10.4067/S0034-98872017000100006.

引用本文的文献

10

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验